HC Wainwright & Co. Maintains Buy on Arcadia Biosciences, Lowers Price Target to $6
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has maintained a Buy rating on Arcadia Biosciences (NASDAQ:RKDA) but lowered the price target from $10 to $6.
May 23, 2024 | 10:15 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
HC Wainwright & Co. has maintained a Buy rating on Arcadia Biosciences but lowered the price target from $10 to $6, indicating a more cautious outlook.
The maintained Buy rating suggests continued confidence in the company's prospects, but the lowered price target indicates a more cautious outlook, likely due to recent performance or market conditions.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100